BANK OF AMERICA CORP /DE/ - Y-MABS THERAPEUTICS INC ownership

Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 100 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of Y-MABS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$187,676
-22.6%
34,436
-3.6%
0.00%
Q2 2023$242,511
-43.4%
35,716
-58.2%
0.00%
Q1 2023$428,129
+279.4%
85,455
+269.6%
0.00%
Q4 2022$112,841
-92.4%
23,123
-77.7%
0.00%
Q3 2022$1,494,000
+43.4%
103,586
+50.3%
0.00%
Q2 2022$1,042,000
-78.0%
68,907
-82.7%
0.00%
Q1 2022$4,738,000
+256.8%
398,823
+386.8%
0.00%
Q4 2021$1,328,000
-42.0%
81,925
+2.1%
0.00%
Q3 2021$2,290,000
-18.0%
80,264
-2.8%
0.00%
Q2 2021$2,791,000
+11.8%
82,570
+0.0%
0.00%
Q1 2021$2,497,000
-17.0%
82,568
+35.9%
0.00%
Q4 2020$3,009,000
+8.6%
60,767
-15.8%
0.00%
Q3 2020$2,770,000
-7.5%
72,170
+4.1%
0.00%
Q2 2020$2,994,000
+69.7%
69,311
+2.5%
0.00%
Q1 2020$1,764,000
-34.6%
67,597
-21.7%
0.00%
Q4 2019$2,699,000
+76.1%
86,382
+46.8%
0.00%
Q3 2019$1,533,000
+247.6%
58,844
+205.6%
0.00%
Q2 2019$441,000
+37.4%
19,258
+57.8%
0.00%
Q1 2019$321,000
+163.1%
12,204
+102.4%
0.00%
Q4 2018$122,000
+2340.0%
6,029
+3056.5%
0.00%
Q3 2018$5,0001910.00%
Other shareholders
Y-MABS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 191,176$2,271,0002.63%
Sofinnova Investments, Inc. 2,194,278$26,068,0001.98%
MPM BioImpact LLC 443,702$5,271,0001.42%
Soleus Capital Management, L.P. 238,982$2,839,0000.37%
Lombard Odier Asset Management (Switzerland) SA 221,774$2,635,0000.21%
Artal Group S.A. 400,000$4,752,0000.20%
Polar Capital Holdings Plc 2,877,671$34,187,0000.15%
ASHFORD CAPITAL MANAGEMENT INC 106,770$1,268,0000.14%
Cormorant Asset Management, LP 150,000$1,782,0000.14%
Virtus ETF Advisers LLC 23,646$281,0000.13%
View complete list of Y-MABS THERAPEUTICS INC shareholders